Sep'05 | Sep'06 | Sep'07 | Sep'08 | Sep'09 | Sep'10 | Sep'11 | Sep'12 | Sep'13 | Sep'14 | Sep'15 | Sep'16 | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 14.7% | 6.7% | 13.4% | (14.2%) | (60.8%) | (2.4%) | 5.6% | (2.5%) | (47.8%) | 0.9% | 6.4% | 15.7% | 30.7% | (4.3%) | (1.7%) | 44.5% | 54.0% | 28.6% | 9.2% | 15.6% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 15.7%, based on the financial report for Sep 28, 2024 (Q3 2024). The average annual Return on Equity (ROE) for Hologic, Inc. have been 25.7% over the past three years, and 25.7% over the past five years.
As of today, Hologic, Inc.'s Return on Equity (ROE) is 15.7%, which is higher than industry median of (3.2%). It indicates that Hologic, Inc.'s Return on Equity (ROE) is Good.